Sign in to view content

Intravitreal Liposome-Encapsulated Bromfenac for the Treatment of Refractory Diabetic Macular Edema

Hugo Quiroz-Mercado, MD

Video
Published 2020

Related

Outcomes of Patients with DME and Baseline BCVA 20/50 or Worse or 20/40 or Better Treated with Aflibercept 8 mg and 2 mg in the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Updates from the Field
2024
Durability of Combination Therapy of Sozinibercept, an Anti-VEGF-C/D 'Trap' With Ranibizumab in nAMD or Aflibercept in DME
Nathan C. Steinle, MD
Annual Meeting Talks
2024
Macular Star
Chuck Terranova
Retina Image Bank: Images of the Week
2016

Category: Diabetic Retinopathy

See more